Literature DB >> 21813069

Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.

Pietro Leccese, Loredana Latanza, Salvatore D'Angelo, Angela Padula, Ignazio Olivieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21813069

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  9 in total

1.  [Update: Behçet's disease].

Authors:  I Kötter
Journal:  Z Rheumatol       Date:  2012-11       Impact factor: 1.372

2.  Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Behçet's disease.

Authors:  Suhail Aamar; Hagit Peleg; David Leibowitz; Tova Chajek-Shaul; Nurith Hiller; Samuel N Heyman
Journal:  Rheumatol Int       Date:  2013-02-15       Impact factor: 2.631

3.  Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.

Authors:  Claudia Fabiani; Antonio Vitale; Giacomo Emmi; Lorenzo Vannozzi; Giuseppe Lopalco; Silvana Guerriero; Ida Orlando; Rossella Franceschini; Daniela Bacherini; Luca Cimino; Alessandra Soriano; Bruno Frediani; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Carlo Salvarani; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-11-16       Impact factor: 2.980

Review 4.  The Use of Biologic Therapies in Uveitis.

Authors:  Sergio Schwartzman; Monica Schwartzman
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 5.  Current and future treatments for Behçet's uveitis: road to remission.

Authors:  Marina Mesquida; Blanca Molins; Victor Llorenç; María Victoria Hernández; Gerard Espinosa; Andrew D Dick; Alfredo Adán
Journal:  Int Ophthalmol       Date:  2013-06-01       Impact factor: 2.031

Review 6.  Adalimumab in the management of Behçet's disease.

Authors:  Atsuhisa Ueda; Mitsuhiro Takeno; Yoshiaki Ishigatsubo
Journal:  Ther Clin Risk Manag       Date:  2015-04-13       Impact factor: 2.423

Review 7.  Anti-TNF-alpha therapy and systemic vasculitis.

Authors:  Pierre-André Jarrot; Gilles Kaplanski
Journal:  Mediators Inflamm       Date:  2014-02-27       Impact factor: 4.711

8.  Behçet's Uveitis: Current Diagnostic and Therapeutic Approach

Authors:  Pınar Çakar Özdal
Journal:  Turk J Ophthalmol       Date:  2020-06-27

9.  Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease.

Authors:  Akihiro Nakamura; Tomoya Miyamura; Eiichi Suematsu
Journal:  Case Rep Rheumatol       Date:  2016-03-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.